Merck Global Health R&D Division visit to Centre for Immunity, Infection and Evolution

  • Event:  Visit from Merck Global Health R&D Division to the Centre for Immunity, Infection and Evolution, University of Edinburgh
  • When:  Afternoon, Tuesday 23 June 2015
  • Location:  Ashworth Laboratories, Kings Buildings

On Tuesday 23 June, the Centre for Immunity, Infection and Evolution at the Ashworth Laboratories, Kings Buildings, is hosting two senior visitors from Merck's new Global Health R&D division.  The Division focuses on drug and diagnostics development for neglected tropical diseases, in particular schistosomiasis, malaria and other fevers that are relevant to their diagnosis.

Jutta Reinhard-Rupp leads the Translational Innovation Platform Projects within Global Health and Claude Oeuvray, Head of Fundraising and Stakeholder Management is tasked with engaging with organisations who could fund Merck's NTD research. Claude recently joined from Medicine for Malaria Venture where he was head of Portfolio Management. Projects are run as public-private partnerships with additional funding from public or private donors.

Jutta and Claude are interested in identifying areas of common research interests and they are currently very active in translating research into health benefits for affected populations. Examples of their work can be seen at:

If you would like to attend their presentation, a networking lunch, or book a 1:1 meeting with them, please register your interest by filling in the Doodle polls below.

Programme of events

If you have any further questions about the Merck visit please contact Francisca Mutapi (; CIIE) or Adam Irvine (; ERI)

Story tags: 

Please tell us what you think about this website !

What do you think of the Edinburgh Infectious Diseases website?  We would be very grateful if you could spare 2 minutes to help us improve the useability and look of our pages. Thank you for your help !